These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 313098)

  • 1. Role of histocompatibility in graft rejection.
    McKenzie IF
    Transplant Proc; 1979 Mar; 11(1):628-32. PubMed ID: 313098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
    Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
    Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular immunology of allograft rejection: insights from MHC mutants and crystal structure.
    DiSesa VJ
    J Heart Lung Transplant; 1991; 10(1 Pt 1):111-6. PubMed ID: 2007162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
    Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
    J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLR blast cells generated in mutant-standard strain combinations bind H-2K and H-2D antigens.
    Geib RW; Klein J
    Eur J Immunol; 1979 Feb; 9(2):135-9. PubMed ID: 155530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic analysis of the H-2D region using a new intra-D-region recombinant mouse strain.
    Duran LW; Zeller JC; Lundy JK; Chang-Miller A; Krco CJ; David CS; Pease LR
    J Immunol; 1987 Oct; 139(8):2818-24. PubMed ID: 3309060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection of skin allografts by CD4+ T cells is antigen-specific and requires expression of target alloantigen on Ia- epidermal cells.
    Rosenberg AS; Katz SI; Singer A
    J Immunol; 1989 Oct; 143(8):2452-6. PubMed ID: 2477443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.
    McKenzie IF; Morgan GM; Sandrin MS; Michaelides MM; Melvold RW; Kohn HI
    J Exp Med; 1979 Dec; 150(6):1323-38. PubMed ID: 159937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the major histocompatibility complex in T cell activation of B cell subpopulations: antigen-specific and H-2-restricted monoclonal TH cells activate Lyb-5+ B cells through an antigen-nonspecific and H-2-unrestricted effector pathway.
    Hodes RJ; Shigeta M; Hathcock KS; Fathman CG; Singer A
    J Immunol; 1982 Jul; 129(1):267-71. PubMed ID: 6177752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection.
    Felix NJ; de Serres S; Meyer AA; Ting JP
    J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans cells, orthotopic corneal allografts, and direct and indirect pathways of T-cell allorecognition.
    Sano Y; Ksander BR; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 May; 41(6):1422-31. PubMed ID: 10798658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participation of class II alloantigens in in vivo regulation of K/D region disparate thyroid graft rejection in mice.
    Isakov N; Bach FH
    J Immunol; 1985 Jun; 134(6):3580-5. PubMed ID: 2859332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute rejection of marrow grafts in mice. Dependence on and independence of functional TCR in the rejection process.
    Takeda K; Moore MW; Dennert G
    J Immunol; 1994 May; 152(9):4407-16. PubMed ID: 8157961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement and antibody-mediated rejection of mouse skin allografts with anti-H-2K, H-2D, H-2L antibodies.
    Capel PJ; de Waal RM; Démant P; Koene RA
    Transplant Proc; 1981 Mar; 13(1 Pt 1):649-53. PubMed ID: 7268885
    [No Abstract]   [Full Text] [Related]  

  • 15. Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHC.
    Rosenberg AS; Mizuochi T; Singer A
    Nature; 1986 Aug 28-Sep 3; 322(6082):829-31. PubMed ID: 3528862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further evidence for two separate loci (H-2D and H-2L) in the D region of the H-2 complex.
    Neauport-Sautes C; Joskowicz M; Demant P
    Transplant Proc; 1979 Jun; 11(2):1322. PubMed ID: 314178
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
    Tomita Y; Mayumi H; Eto M; Nomoto K
    J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-dominant restriction by a mixed-haplotype I-A molecule (alpha k beta b) for the lysozyme peptide 52-61 in H-2k x H-2b F1 mice.
    Moreno J; Adorini L; Hämmerling GJ
    J Immunol; 1990 May; 144(9):3296-304. PubMed ID: 1970351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique.
    Fan X; Tyerman K; Ang A; Koo K; Parameswaran K; Tao K; Mai L; Lang H; West LJ
    Transplant Proc; 2005; 37(1):29-31. PubMed ID: 15808536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic T lymphocyte responses against alloantigens exhibit preferential effector cell activity for H-2K or H-2D region products similar to that for H-2 restricted responses.
    Lucas CJ; Levy RB; Shearer GM
    J Immunol; 1981 Apr; 126(4):1255-9. PubMed ID: 6970767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.